文献速递呼吸道感染呼吸危重症与机械通气

一例67岁男性COVID-19患者呼吸功能恶化并急性肾衰竭

A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure.
PubMed 文献 · Chest · 2022-01-01

一例67岁肥胖男性(BMI 38.0)合并2型糖尿病、慢性房颤及慢性淋巴细胞白血病(化疗后稳定8年)且有吸烟史,因SARS-CoV-2感染出现进行性呼吸困难和发热就诊。入院后接受地塞米松(6 mg IV 每日一次)和氧疗,第3天低氧血症加重转入ICU行有创机械通气,继续地塞米松并给予单剂托珠单抗(800 mg)。ICU第9天支气管镜见气管白色斑块提示侵袭性曲霉性气管支气管炎,启动伏立康唑后病情急剧恶化。

要点

  • 肥胖、糖尿病、血液肿瘤病史的COVID-19患者应警惕重症化。
  • 有创机械通气后出现气管白色斑块需考虑侵袭性曲霉性气管支气管炎。
  • 该患者启动伏立康唑后病情仍急剧恶化,提示预后极差。

核心结论

  • 该病例报告未给出明确结论,仅描述一例COVID-19患者在ICU治疗期间出现侵袭性曲霉性气管支气管炎疑似诊断并启动伏立康唑后病情急剧恶化。

研究设计与样本

  • 单例病例报告,对象为67岁男性COVID-19患者。

主要发现

  • 患者BMI 38.0,合并2型糖尿病、慢性房颤、慢性淋巴细胞白血病II期(化疗后稳定8年)及吸烟史。
  • 入院第3天因进行性低氧血症转入ICU行有创机械通气,继续地塞米松并给予单剂托珠单抗800 mg。
  • ICU第9天支气管镜见气管白色斑块,提示侵袭性曲霉性气管支气管炎,启动伏立康唑后病情急剧恶化。

临床怎么用

  • 对重症COVID-19长期使用糖皮质激素及机械通气患者,应警惕侵袭性曲霉性气管支气管炎可能。

局限性

  • 单例病例报告,无法推断因果关系或疗效。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

A 67-year-old obese man (BMI 38.0) with type 2 diabetes mellitus (DM), chronic atrial fibrillation, and chronic lymphocytic leukemia stage II, stable for 8 years after chemotherapy, and a history of smoking presented to the ED with progressive dyspnea and fever due to SARS-CoV-2 infection. He was admitted to a general ward and treated with dexamethasone (6 mg IV once daily) and oxygen. On day 3 of hospital admission, he became progressively hypoxemic and was admitted to the ICU for invasive mechanical ventilation. Dexamethasone treatment was continued, and a single dose of tocilizumab (800 mg) was administered. On day 9 of ICU admission, voriconazole treatment was initiated after tracheal white plaques at bronchoscopy, suggestive of invasive Aspergillus tracheobronchitis, were noticed. However, his medical situation dramatically deteriorated.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Melchers M, Festen B, den Dekker BM, et al. A 67-Year-Old Male Patient With COVID-19 With Worsening Respiratory Function and Acute Kidney Failure. Chest. 2022. PMID: 35000717. doi:10.1016/j.chest.2021.08.045

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。